• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells

    2014-03-21 03:36:07
    Chinese Journal of Cancer Research 2014年6期

    Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

    Correspondence to: Jing Zhang, MD. Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Rd, Xicheng District, Beijing 100050, China. Email: 13910178021@139.com.

    Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells

    Jing Zhang, Cang Liu, Ruiguang Hou

    Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

    Correspondence to: Jing Zhang, MD. Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Rd, Xicheng District, Beijing 100050, China. Email: 13910178021@139.com.

    Background:The purposes of this study were to explore the effects of high mobility group protein box 1 (HMGB1) gene on the growth, proliferation, apoptosis, invasion, and metastasis of glioma cells, with an attempt to provide potential therapeutic targets for the treatment of glioma.

    Methods:The expressions of HMGB1 in glioma cells (U251, U-87MG and LN-18) and one control cell line (SVG p12) were detected by real time PCR and Western blotting, respectively. Then, the effects of HMGB1 on the biological behaviors of glioma cells were detected: the expression of HMGB1 in human glioma cell lines U251 and U-87MG were suppressed using RNAi technique, then the infuences of HMGB1 on the viability, cycle, apoptosis, and invasion abilities of U251 and U-87MG cells were analyzed using in a Transwell invasion chamber. Also, the effects of HMGB1 on the expressions of cyclin D1, Bax, Bcl-2, and MMP 9 were detected.

    Results:As shown by real-time PCR and Western blotting, the expression of HMGB1 signifcantly increased in glioma cells (U251, U-87MG, and LN-18) in comparison with the control cell line (SVG p12); the vitality, proliferation and invasive capabilities of U251 and U-87MG cells in the HMGB1 siRNA-transfected group were signifcantly lower than those in the blank control group and negative control (NC) siRNA group (P<0.05) but showed no signifcant difference between the blank control group and NC siRNA group. The percentage of apoptotic U251 and U-87MG cells was signifcantly higher in the HMGB1 siRNA-transfected group than in the blank control group and NC siRNA group (P<0.05) but was similar between the latter two groups. The HMGB1 siRNA-transfected group had signifcantly lower expression levels of Cyclin D1, Bcl-2, and MMP-9 protein in U251 and U-87MG cells and signifcantly higher expression of Bax protein than in the blank control group and NC siRNA group (P<0.05); the expression profles of cyclin D1, Bax, Bcl-2, and MMP 9 showed no signifcant change in both blank control group and NC siRNA group.

    Conclusions:HMGB1 gene may promote the proliferation and migration of glioma cells and suppress its effects of apoptosis. Inhibition of the expression of HMGB1 gene can suppress the proliferation and migration of glioma cells and promote their apoptosis. Our observations provided a new target for intervention and treatment of glioma.

    High mobility group protein box 1 (HMGB1); glioma; proliferation; apoptosis; invasion; siRNA

    View this article at:http://dx.doi.org/10.3978/j.issn.1000-9604.2014.12.05

    Introduction

    A glioma is a primary brain tumor that originates from the nerve stromal cells including glial cells, ependymal cells, choroid plexus epithelial cells, and nerve parenchymal cells. Gliomas are featured by high morbidity, high recurrence rate, and high case-fatality rate (with an overall 5-year survival of only 13%), and low cure rate. Gliomas account for about 60% of all intracranial primary brain tumors, posing serious threat to the life and health of patients (1,2). Tumor invasion and metastasis are important biological characteristics of malignant tumors. Most patients who dieof cancer die from metastatic disease rather than from the primary lesion (3,4). Gliomas are highly invasive. They often invade the surrounding normal brain tissue, and have no clear boundaries with normal brain tissues. Thus, surgery has only a limited role in treatment, and the casefatality rate of gliomas is extremely high (1,5,6).

    Cancers are caused by the accumulation of genetic mutations, including the activation of oncogenes and the loss of tumor suppressor genes. Activation of oncogenes can lead to cell malignant transformation and tumorigenesis (7-9). Most studies have shown that the activation of oncogenes play key roles in the occurence and development of gliomas (10-12). Activation of oncogenes usually involves the changes in multiple signaling pathways, cell cycle, and regulation of apoptosis (13-16). Recent research has shown that the high mobility group protein box 1 (HMGB1) gene is highly expressed in various tumours, showing oncogene-like functions (17-19). Forty years ago, HMGB1 was discovered in calf thymus and named according to its electrophoretic mobility in polyacrylamide gels (20). Human HMGB1 is a structural transcription factor encoded by a single gene. Located in chromosome 13q12, it contains four introns and fve exons, encoding a 215-aminoacid protein, with a molecular weight of about 30 KD. It is highly conserved, with an amino acid sequence homology of over 98% between human and rodents (21,22). HMGB1 protein is divided into three domains: two positively charged DNA-binding motifs (boxes A, B) and a C-terminal acidic tail. Both the two motifs contain 80-90 amino acid residues and are strongly alkaline; and the carboxy terminus, also known as acidic terminal, is rich in aspartic acid and glutamic acid containing negative charge (23). HMGB1 is a multifunctional protein. HMGB1 functions as a DNA-binding protein in the nucleus; by binding DNA with specific structures, it can affect the structural state of the target sequence and thus participates in the key life activities including the division, differentiation, and maturation of cells, DNA repair, DNA recombination, regulation by steroid hormones, and regulation of gene transcription (24-27). Outside the cells, HMGB1 released by necrotic cells or activated immune cells is a typical injury-related molecule, which, by interacting with cytokines, chemokines, and growth factors, is involved in the various activities of cells (20). HMGB1 protein, as a ubiquitous nuclear protein, is widely distributed in mammalian cells, in particular in thymus, lymph tissue, testis, and neonatal liver (28). As shown in recent research, high expression of HMGB1 has also been detected in immature cells and a variety of solid tumors. HMGB1 is an anti-apoptotic protein; its over-expression can suppress apoptosis and thus cause the occurrence and development of tumors (29). In addition, HMGB1 is also related with the activation of the plasminogen system and matrix metalloproteinases and the migration of adherent cells (30,31). HMGB1 has been found to be highly expressed in many malignancies including colon cancer, lung cancer, breast cancer, nasopharyngeal carcinoma, and head and neck squamous cell carcinoma (32-36), and may also be closely associated with the occurrence, invasion, and metastasis of tumors. However, the specifc mechanisms governing the biological activities of HMGB1 remain unclear, and few studies have explored the role ofHMGB1 in the development of glioma cells. Thus, in our current study, we inhibited the expression of HMGB1 gene in U251 and U-87MG cell lines using the gene knockout method; then, we detected the change of the biological characteristics of this cell line to analyze the effect of HMGB1 on the biological behaviors of glioma cells and explore the relationship between HMGB1 and the development, invasion, and metastasis of glioma, with an attempt to provide scientifc evidences for the prognosis and targeted therapy of gliomas.

    Materials and methods

    Materials

    Trizol reagent and RT-PCR kit were purchased from BioRad Company (Richmond, CA, USA), HMGB1 siRNA oligonucleotides targeting human HMGB1, control oligonucleotides [HMGB1 siRNA negative control (NC)] and transfection reagents were from RiboBio (Guangzhou, China). Trypsin, methyl thiazolyl tetrazolium (MTT), propidium iodide (PI), and dimethyl sulfoxide (DMSO) were from Sigma Corp. (St. Louis, Missouri, USA), Annexin V-FITC was purchased from Beyotime (Haimen, China). Human HMGB1 (NM_002128.4) upstream primer (GGAGAGTAATGTTACAGAGCGG) and downstream primer (AGGATCTCCTTTGCCCATGT) were synthesized by Shanghai Biological Engineering Technology Services Limited (Shanghai, China). Matrigel was purchased from BD Bioscience (San Jose, CA, USA), and transwell invasion chamber was from Corning Corp. (Midland, Michigan, USA). Protein extraction and protein quantification kits were purchased from Bio-Rad (Richmond, CA, USA). Rabbit anti-HMGB1 and rabbit anti-Bax polyclonal antibodies were fromAbcam (Cambridge, MA, USA). Rabbit anti-matrix metalloproteinase-9 (MMP-9) polyclonal antibody was from LifeSpan Biosciences (Seattle, WA, USA). Rabbit anti-Bcl-2 polyclonal antibody and mouse anti-cyclin D1 polyclonal antibody were from Biorbyt (Cambridge, UK). Rabbit antitubulin polyclonal antibody was from Abbiotec (San Diego, CA, USA). Horseradish peroxidase conjugated goat antirabbit or rabbit anti-mouse IgG polyclonal antibody was from Invitrogen-Life Technologies (Carlsbad, CA, USA). ECL chemoluminescence kit was from Pierce Company (Rockford, Illinois, USA).

    U251 and U-87MG cell culture and HMGB1 siRNA transfection

    Human glioma cell lines U251 and U-87MG were purchased from ATCC (Rockville, MD, USA). The U251 and U-87MG cells were cultured at 37 ℃ in an environment with saturated humidity and 5% CO2in the Eagle’s minimum essential medium (Eagle’s MEM) (Rickmansworth, England) containing 10% fetal bovine serum (Gibco Company, Grand Island, NY, USA), penicillin (100 U/mL), and streptomycin (100 μg/mL). Cells in the exponential phase were selected for further experiment. One day before transfection, the U251 and U-87MG cells at the logarithmic phase were digested with trypsin and then counted. Cells were inoculated in 6-well plates at an appropriate density. On the transfection day, after the cells were 90% confluent, they were treated overnight with Eagle’s MEM without serum. According to manufacturer’s instruction, the U251 and U-87MG cells in the exponential phase were transfected with HMGB1 siRNA (inhibiting HMGB1 mRNA) and NC siRNA (scrambled the nucleotide sequence of HMGB1 siRNA lacked homology to any other gene). Three groups were set: HMGB1 siRNA group, NC siRNA group and blank control group (transfected with only transfection reagents). The transfection and inhibition rates of HMGB1 siRNA were detected using Western blotting.

    Cell viability: analysis by MTT test

    Cell viability following HMGB1 knockdown was assessed by MTT test. In the Eagle’s minimum essential medium (Eagle’s MEM) containing 10% FBS, the U251 and U-87MG cells were prepared into single cell suspensions and then inoculated in the 96-well plates with 2,000 cells/well in 200 μL. The wells were then cultured in an incubator (37 ℃ and 5% CO2) until monolayers were obtained, which were adherent 24 hours later. Add 100 μL MTT solution (0.5 mg/mL) in each well, and then put the plate into the incubator to allow the cell culture process to continue. After 4 hours of culture, the medium was removed and 150 μL DMSO was added to each well. Then plates were placed on shaker for 10 min to fully dissolve the crystals. The OD value was measured at a wavelength of 570 nm. With this procedure, only viable cells with functioning mitochondria can oxidize MTT to a violet-red reaction product.

    Cell proliferation: analysis by fl ow cytometry

    Cell proliferation following HMGB1 knockdown was assessed by flow cytometry. After the cells were 70-80% confluent, they were refed with serum-free medium for 24 hours; after have been synchronized, they were cultured in complete medium for another 24 hours. Cells were collected (about 1×106-5×106/mL) and centrifuged at 800 r/min for 5 min to discard the culture medium. After the cells were washed with 3 mL PBS once, the mixture was centrifuged to remove PBS solution, and then added with ice-cold 70% ethanol and fxed at 4 ℃ for 1-2 hours. Discard the fxative by centrifugation. Resuspend the cells in 3 mL PBS for 5 min. After fltering through the 400-mesh flter cloth, the mixture was centrifuged at 800 r/min for 5 min to discard the PBS. Add 1 mL of PI staining solution and incubate 30 minutes in the dark at 4 ℃. Detection using flow cytometer: for PI, cells were excited with an Argon 488 nm laser and emission of radiation at wavelengths of larger than 630 nm. Fluorescence intensity histogram profles of the PI were analyzed using red fuorescence. For cell cycle analysis, data were expressed as fractions of cells in different cycle phases. Measurements repeated three times in each group.

    Detection of cell apoptosis by fl ow cytometry

    Apoptosis was assayed using the Annexin V-FITC Apoptosis Kit (Haimen, China) according to the manufacturer’s instructions. Briefly, after the cell culture medium was dried, the adherent cells were washed with PBS once, and then a proper amount of trypsin-EDTA solution was added to digest the cells. The cells were further inoculated at room temperature until they could be dispersed with gentle pipetting. Then, the trypsin-EDTA solution was removed. Add cell culture medium again, and then the mixture was transferred to a centrifuge tube. Centrifuge the cells at 1,000 rpmfor 5 min. After the supernatant was discarded, add PBS and gently resuspended cells. Then, the cells were counted. Collect 50,000-100,000 resuspended cells, centrifuge them at 1,000 rpm for 5 min, and then discard the supernatant. A total of 195 μL annexin V-FITC liquid and 5 μL annexin V-FITC were added gently to the suspended cells, mixed gently, and incubated in room temperature (20-25 ℃) at dark for 10 minutes (aluminum foil can be used to avoid light). Centrifuge for 5 minutes, and then the supernatant was discarded. A total of 190 μL annexin V-FITC liquid was added gently to the suspended cells. A total of 10 μL of PI staining solution was added, gently mixed, and incubated in ice bath at dark. Samples were analyzed by fow cytometry. Stain the cells simultaneously with FITC-Annexin V (green fuorescence) and PI (red fuorescence). Data were analyzed using Cell Quest software. Measurements repeated three times in each group.

    Determination of invasion of glioma cells

    The invasive ability of U251 and U-87MG glioma cells was assessed through the number of cells passed through an 8-μm pore size polycarbonate flter coated with Matrigel (Corning, MA, USA). The chamber was washed with serum-free medium three times. Add 20 μL appropriately diluted Matrigel, which was evenly covered on the surface of polycarbonate membrane. Inoculate at 37 ℃ for 30 min to create an artifcial basement membrane. Thus, the chamber was divided into upper and lower chambers. In each group (HMGB1 siRNA group, NC siRNA group, and blank control group), the cells (2×105cells) were suspended in 200 μL serum-free Eagle’s MEM medium, and then inoculated in the upper chamber of the transwell invasion system. Add 500 μL Eagle’s MEM medium containing 10% FBS, put the cells in the incubator, and then culture them for 24 hours. Take out the upper chamber, remove the cells on the surface of the upper chamber using sterile cotton swab and stain the cells that had invaded the lower surface of the basement membrane using crystal violet. Count the number of cells that had passed through the transwell polycarbonate membrane using Leica microscope (Leica Company, Wetzlar, Germany). Eight visual fields were randomly observed for each sample, and the experiment was repeated three times.

    RNA isolation and real-time PCR

    Total RNA was extracted from U251 and U-87MG glioma cells with Trizol reagent as per the manufacturer’s protocol and subjected to reverse transcription using a reverse transcription primer. Real-time PCR reactions were performed using the iTaq Fast SYBR Green Supermix (BioRad) exactly following the manufacturer’s instructions and Applied Biosystems 7500 real-time PCR system. Relative quantification was performed by using the comparative Ct method and all results were compared to the control samples after normalizing to an endogenous control [Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)]. Values are expressed as mean percent ± SE.

    Western blotting

    The total proteins were extracted using protein extraction kit, and the protein concentration was analyzed using a BCA assay kit (Bio-Rad, Richmond, CA, USA). The total proteins of 40 μg per hole were subject to SDS-PAGE gel electrophoresis. After the protein had been transferred onto a PVDF membrane (Millipore Company, Bedford, MA, USA), they were blocked in TBS solution (10 mM Tris-HCl, pH 7.5, 150 mM NaCl) containing 5% skimmed milk powder at room temperature for 1 h, then added with cyclin D1, Bax, Bcl-2, and MMP-9 primary antibody and incubated overnight at 4 ℃. Wash 3 times with fresh TBST for 5 minutes. Add HRP-labeled goat antirabbit IgG or rabbit anti-mouse polyclonal antibody and inoculate at 37 ℃ for 1 h. Wash 3 times with fresh TBST for 5 minutes. Autoradiography was conducted using ECL chemiluminescent substrate. The change of its relative expression was analyzed using PDQuest software (Bio-Rad, Richmond, CA, USA).

    Statistical analysis

    The experimental data were analyzed using SPSS 17.0 software. Inter-group differences were analyzed by t-test and multiple comparisons among several groups were conducted by analysis of variance. P<0.05 was considered significantly different.

    Results

    High expression of HMGB1 in glioma cell lines

    Figure 1Expression of HMGB1 in glioma cell lines. (A) Expression of HMGB1 mRNA in glioma cell lines; (B) expression of HMGB1 protein in glioma cell lines; (C) relative expression of HMGB1 protein in glioma cell lines; (D) expression of HMGB1 protein in glioma cell lines; (E) relative expression of HMGB1 protein in glioma cell lines. *, P<0.05. HMGB1, high mobility group protein box 1.

    Figure 2Effect of HMGB1 gene on the viability of U251 and U-87MG cells. *, P<0.05. HMGB1, high mobility group protein box 1.

    Real-time PCR and western blotting showed that, compared with the immortalized human astrocytes (SVG-p12 cell line), the expressions of HMGB1 mRNA and protein signifcantly increased in glioma cell lines (U251, U-87MG, and LN-18) (P<0.05) (Figure 1A-C). U251 and U-87MG cells were selected for further study. We inhibited the HMGB1 expression in U251 and U-87MG cells by RNAi technique. As shown in Western blotting, the expression of HMGB1 in U251 and U-87MG cells was significantly inhibited in HMGB1 siRNA group but showed no significant difference in the NC siRNA group and blank control group (Figure 1D,E). Thus, the HMGB1-knockout cell model was successfully established.

    Effect of HMGB1 gene on the viability of glioma cells

    After the inoculation of equal volume of U251 and U-87MG cells in HMGB1 siRNA group, NC siRNA group, and blank control group, MTT assay showed that the viability of U251 and U-87MG cells was signifcantly lower in the HMGB1 siRNA group than in the NC siRNA group and blank control group (P<0.05) but was not significantly changed in the NC siRNA group and blank control group (Figure 2). Thus, the knockdown of HMGB1 gene may lower the viability of U251 and U-87MG cells, whereas the overexpression of HMGB1 gene may be associated with the increased vitality of U251 and U-87MG cells.

    Effect of HMGB1 on the proliferation of glioma cells

    Figure 3Effect of HMGB1 gene on the cell cycle of U251 and U-87MG cells. *, P<0.05. (A-C,E-G) are the fow chart for analyzing the cell cycle; (D,H) the proliferation index of U251 and U-87MG cells. HMGB1, high mobility group protein box 1.

    After the inoculation of equal volume of U251 and U-87MG cells in HMGB1 siRNA group, NC siRNA group, and blank control group, flow cytometry after PI staining showed that the number of U251 and U-87MG cells in G0/ G1 phases were signifcantly larger in the HMGB1 siRNA group than in the NC siRNA group and blank control group (P<0.05), whereas the numbers of cells in S phase and G2/M phases were significantly smaller (P<0.05); in contrast, the numbers of U251 and U-87MG cells in G1 phase, S phase, and G2/M phase showed no significant change in the NC siRNA group and the blank control group (Figure 3). Thus, the changes in the expression profle of HMGB1 gene may be related with the changes in the cell cycle of U251 and U-87MG glioma cells. More specifcally, the suppressed expression of HMGB1 gene may be related with the cell-cycle G0/G1 phase arrest in U251 and U-87MG cells; or, the proliferation of U251 and U-87MG cells can be suppressed by inhibiting the expression of HMGB1 gene.

    Effect of HMGB1 on Apoptosis of glioma cells

    Figure 4Effect of HMGB1 gene on the apoptosis of U251 and U-87MG cells. *, P<0.05. HMGB1, high mobility group protein box 1.

    Figure 5Effect of HMGB1 gene on the migration of U251 and U-87MG cells. *, P<0.05. HMGB1, high mobility group protein box 1.

    As shown by annexin V and PI staining, the HMGB1 siRNA group had signifcantly larger number of apoptotic U251 and U-87MG cells than the NC siRNA group and blank control group (P<0.05); however, no significant difference was found between the NC siRNA group and blank control group (P<0.05) (Figure 4). Therefore, the HMGB1 gene knockdown may inhibit the apoptosis of U251 and U-87MG cells.

    Effect of HMGB1 gene on the invasion ability of glioma cells

    The invasive ability of U251 and U-87MG glioma cells was assessed through the number of cells passed through an 8-μm pore size polycarbonate filter coated with matrigel. As shown by the transwell invasion chamber assay, the number of cells passed through the polycarbonate filter was significantly smaller in the HMGB1 siRNA group than in the NC siRNA group and blank control group (P<0.05); however, no such different was found between the NC siRNA group and the blank control group (Figure 5). Therefore, the change of the HMGB1 protein expression level may be associated with the change of the invasion ability of U251 and U-87MG glioma cells. Knockout of HMGB1 gene may inhibit the invasiveness of U251 and U-87MG cells.

    Effects of HMGB1 on cyclin D1, Bax, Bcl-2 and MMP-9 protein expressions

    As shown by Western blotting, the HMGB1 siRNA group had signifcantly lower expression levels of cyclin D1, Bcl-2 and MMP-9 proteins and higher Bax protein expression level than the NC siRNA group and the blank control group (P<0.05); however, the protein expression profles of cyclin D1, Bax, Bcl-2, and MMP-9 in U251 and U-87MG cells were not significantly changed in the NC siRNA group and the blank control group (Figure 6). Thus, the suppressed expression of HMGB1 may be associated with the down-regulated expressions of cyclin D1, Bcl-2, and MMP-9 protein and the up-regulated expression of Bax protein.

    Discussion

    HMGB1 is widely distributed in all mammalian tissues. The HMGB1 inside the nucleus and outside the cells exert different functions and biological effects. By binding DNA with specific structures, HMGB1 inside the nucleus can affect the structural state of the target sequence and thus participates in the key life activities including the division, differentiation, and maturation of cells, DNA repair, DNA recombination, regulation by steroid hormones, and regulation of gene transcription (24,25). In contrast, HMGB1 outside the cells can bind multiple receptors and thus exert different functions. It has been widely recognized that the main extracellular HMGB1 receptors include Tolllike receptors (TLRs) and receptor for advanced glycation end products (RAGE). The biological effects of HMGB1 are realized primarily through the interactions between RAGE and TLRs (37). Currently, the biological research on HMGB1 is mainly focused on the late inflammatory mediators, autoimmune diseases, axon growth, and tumor development and metastasis (25,33,38).

    HMGB1 is a typical damage-associated molecular pattern (DAMP). Recent studies have demonstrated that HMGB1 is associated with the progression, invasion, and metastasis of tumors and has abundant expressions in a variety of tumor tissues and immature cells (39). HMGB1 is not only an important cytokine (40) but also closely related with tumors (41). HMGB1 has been found to be highlyexpressed in many malignancies including colon cancer, pancreatic cancer, breast cancer, nasopharyngeal carcinoma, and head and neck squamous cell carcinoma (38). Specifc inhibition of the HMGB1 expression can suppress the malignant changes including the proliferation and invasion of tumor cells. However, few studies have reported the relationship between HMGB1 and the development of gliomas. In our current in vitro study, we tried to explore the role of HMGB1 gene in the U251 and U-87MG cells.

    Figure 6Effects of HMGB1 on cyclin D1, Bax, Bcl-2 and MMP-9 protein expressions. (A,C) Expression of proteins in U251 and U-87MG cells in the NC siRNA group; (B,D) relative expression of proteins in U251 and U-87MG cells in the NC siRNA group (a: HMGB1 siRNA group; b: NC siRNA groups; c: blank control group, *, P<0.05). HMGB1, high mobility group protein box 1.

    First, real-time PCR and Western blotting demonstrated the high expressions of HMGB1 mRNA and HMGB1 protein in glioma cell lines (U251, U-87MG, and LN-18), which was consistent with the previous reports on other tumors (32-36,42), suggesting that the up-regulated HMGB1 expression plays a key role in the development of gliomas. Thus, we further established a HMGB1-knockout cell model to investigate the role of HMGB1 in glioma cells. After the expression of HMGB1 in U251 and U-87MG cells was inhibited using the RNAi technique, the expression of HMGB1 in the U251 and U-87MG cells in the HMGB1 siRNA group was significantly suppressed, indicating that the HMGB1-knockout cell model was successfully established. Then, we explored the relationship between the changes in the HMGB1 expression and the biological characteristics of U251 and U-87MG cells. By using MTT method and PI staining, we detected the influences of HMGB1 gene on the growth, proliferation, and cell cycle of U251 and U-87MG cells. MTT assay indicated that the knockdown of HMGB1 gene may be associated with the decreased viability of U251 and U-87MG cells. PI staining showed that the decrease in the HMGB1 gene expression may be related with the G0/G1 arrest of U251 and U-87MG cells. These fndings might be explained by the speculation that the expressions of the growth-promoting factors in the downstream signal transduction pathways of HMGB1 gene decrease and/or the growth-inhibiting factors increase. Therefore, we further detected the expression of cyclin D1, a positive regulator of the cell cycle (43) and found that the expression of cyclin D1 was signifcantly inhibited in the HMGB1 siRNA group. It is then speculated that the cell cycle of U251 and U-87MG cells in the HMGB1 siRNA group was blocked, which may be caused by thedecreased expression of cyclin D1 protein; however, the exact mechanism remains unclear. We further used annexin V-FITC staining to investigate the effect of HMGB1 on apoptosis in U251 and U-87MG cells, and the results showed that the number of apoptotic U251 and U-87MG cells were signifcantly larger in the HMGB1 siRNA group than in the blank control group and NC siRNA group, suggesting that the decreased expression of HMGB1 might promote the apoptosis of U251 and U-87MG cells. It was found that the HMGB1 in Lewis cells could inhibit the expression of pro-apoptosis protein Bax and promote the expression of anti-apoptosis protein Bcl-2 (29). Was there any similar regulation pattern in the U251 and U-87MG cells? To answer this question, we detected the expressions of Bax and Bcl-2 and found that the expression level of antiapoptosis protein Bcl-2 signifcantly decreased and the proapoptosis protein Bax protein level significantly increased in U251 and U-87MG cells in the HMGB1 siRNA group, which may explain the obvious apoptosis in U251 and U-87MG cells in the HMGB1 siRNA group. Some authors also found that the overexpression of HMGB1 could inhibit the activities of caspase-9 and caspase-3, suggesting that HMGB1 could inhibit the apoptosis (34). Thus, the inhibition of HMGB1 gene expression may inhibit the growth and proliferation of glioma cells and promote the apoptosis; overexpression of HMGB1 may promote the growth and proliferation of glioma cells and inhibit the apoptosis.

    Recent studies have also found that the expression of HMGB1 is closely associated with the invasive growth of tumors, formation of metastatic lesions, and the poor prognosis (18,19,44-46). Thus, HMGB1 also plays a key role during tumor invasion and metastasis. In our current study, we used transwell invasion chamber assay to explore the effect of HMGB1 gene on the invasion ability of U251 and U-87MG cells and found that the number of U251 and U-87MG cells passed through the polycarbonate flter was signifcantly smaller in the HMGB1 siRNA group than in the NC siRNA group and blank control group, suggesting that the change in the HMGB1 protein expression level may be related with the invasion ability of U251 and U-87MG cells; in other words, knockout of HMGB1 gene may inhibit the invasiveness of U251 and U-87MG cells. HMGB1 can bind with its ligands RAGE and TLR and then induce the growth and migration of cells via its intracellular signaling pathways including NF-κB, MAPK, and ERK (47,48). It has been reported that the knockdown of HMGB1 by siRNA inhibited cell invasive potential, and down regulated the expression of NF-κB p65 and MMP-9 in gastric cancer cells (19). Exogenous HMGB1 induced the rapid phosphorylation of NF-κB and up regulated the expression of MMP-9 (49). Many other studies found that the changes in the expression of MMP-9 were significantly associated with the cell-matrix adhesion capacity (50-52). In addition, MMP-9 was found to be closely associated with tumor infiltration and metastasis (53-56). In our current study, we further explored the effect of HMGB1 on the expression of MMP-9 in U251 and U-87MG cells. We found that the expression of MMP-9 protein was significantly inhibited in the U251 and U-87MG cells in the HMGB1 siRNA group, indicating that the HMGB1 knockdown may down-regulate the expression of MMP-9 in U251 and U-87MG cells and thus exert its function in suppressing tumor infiltration and metastasis. However, its exact mechanism requires further study.

    Conclusions

    In conclusion, the up-regulated expression of HMGB1 may play key roles in the occurrence, development, invasion and metastasis of gliomas. Further understanding of the specifc mechanisms via which HMGB1 regulates the development of gliomas will shed light on the new strategies and new targets for treating gliomas.

    Acknowledgements

    Disclosure: The authors declare no confict of interest.

    1. Rees JH. Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol 2011;84 Spec No 2:S82-9.

    2. Osman MA. Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas. Ann Transl Med 2014;2:44.

    3. Al-Mulla F, Bitar MS, Al-Maghrebi M, et al. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3 . Cancer Res 2011;71:1334-43.

    4. Wang J, Ma Y, Cooper MK. Cancer stem cells in glioma: challenges and opportunities. Transl Cancer Res 2013;2:429-41.

    5. Cai LB, Li J, Lai MY, et al. Bevacizumab rescue therapy extends the survival in patients with recurrent malignant glioma. Chin J Cancer Res 2013;25:206-11.

    6. Chen Y, Liu D. Chimeric antigen receptor (CAR)-directedadoptive immunotherapy: a new era in targeted cancer therapy. Stem Cell Investigation 2014;1:2.

    7. Ngalame NN, Tokar EJ, Person RJ, et al. Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic. Toxicol Sci 2014;138:268-77.

    8. Shrestha Y, Schafer EJ, Boehm JS, et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 2012;31:3397-408.

    9. Baskaran D, Spirin PV, Prasolov VS. Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells. Mol Biol (Mosk) 2010;44:418-30.

    10. Boccaccio C, Comoglio PM. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target. Cancer Res 2013;73:3193-9.

    11. Li J, Gupta S, Li C. Research perspectives: gold nanoparticles in cancer theranostics. Quant Imaging Med Surg 2013;3:284-91.

    12. Feng H, Hu B, Vuori K, et al. EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180. Oncogene 2014;33:2504-12.

    13. Ibrahim NY, Abdel Aal HH, Abdel Kader MS, et al. Reducing late effects of radiotherapy in average risk medulloblastoma. Chin Clin Oncol 2014;3:3.

    14. Paul AG, Chandran B, Sharma-Walia N. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor infammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies. Transl Res 2013;162:77-92.

    15. McCubrey JA, Demidenko ZN. Recent discoveries in the cycling, growing and aging of the p53 feld. Aging (Albany NY) 2012;4:887-93.

    16. Gandarillas A. The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint. Cell Cycle 2012;11:4507-16.

    17. Süren D, Y ld r m M, Demirpen?e ?, et al. The role of high mobility group box 1 (HMGB1) in colorectal cancer. Med Sci Monit 2014;20:530-7.

    18. Xiao J, Ding Y, Huang J, et al. The association of HMGB1 gene with the prognosis of HCC. PLoS One 2014;9:e89097.

    19. Zhang J, Kou YB, Zhu JS, et al. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF- B pathway in vitro and in vivo. Int J Oncol 2014;44:1268-76.

    20. Kang R, Zhang Q, Zeh HJ 3rd, et al. HMGB1 in cancer: good, bad, or both? Clin Cancer Res 2013;19:4046-57.

    21. Riuzzi F, Sorci G, Donato R. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth. Am J Pathol 2007;171:947-61.

    22. Ditsworth D, Zong WX, Thompson CB. Activation of poly (ADP)-ribose polymerase (PARP-1) induces release of the pro-infammatory mediator HMGB1 from the nucleus. J Biol Chem 2007;282:17845-54.

    23. Zhang CL, Shu MG, Qi HW, et al. Inhibition of tumor angiogenesis by HMGB1 A box peptide. Med Hypotheses 2008;70:343-5.

    24. Dong Xda E, Ito N, Lotze MT, et al. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. J Immunother 2007;30:596-606.

    25. Tang D, Kang R, Zeh HJ 3rd, et al. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010;1799:131-40.

    26. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001;26:152-3.

    27. Bonaldi T, L?ngst G, Strohner R, et al. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J 2002;21:6865-73.

    28. Mosevitsky MI, Novitskaya VA, Iogannsen MG, et al. Tissue specifcity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem 1989;185:303-10.

    29. Xu X, Zhu H, Wang T, et al. Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways. Scand J Immunol 2014;79:386-94.

    30. Gnanasekar M, Kalyanasundaram R, Zheng G, et al. HMGB1: A Promising Therapeutic Target for Prostate Cancer. Prostate Cancer 2013;2013:157103.

    31. Carvajal IM, Baron RM, Perrella MA. High-mobility group-I/Y proteins: Potential role in the pathophysiology of critical illnesses. Crit Care Med 2002;30:S36-42.

    32. Akaike H, Kono K, Sugai H, et al. Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. Anticancer Res 2007;27:449-57.

    33. Thomas JO, Travers AA. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 2001;26:167-74.

    34. V?lp K, Brezniceanu ML, B?sser S, et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006;55:234-42.

    35. Ranganathan A, Gunnarsson O, Casarett D. Palliative care and advance care planning for patients with advanced malignancies. Ann Palliat Med 2014;3:144-9.

    36. Lam S, Lin Y, Warnke PC. Permeability imaging in pediatric brain tumors. Transl Pediatr 2014;3:218-28.

    37. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007;13:1050-9.

    38. Moriwaka Y, Luo Y, Ohmori H, et al. HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer. Pathobiology 2010;77:17-23.

    39. Fukami A, Adachi H, Yamagishi S, et al. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Metabolism 2009;58:1688-93.

    40. Yang H, Tracey KJ. Targeting HMGB1 in infammation. Biochim Biophys Acta 2010;1799:149-56.

    41. Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354-60.

    42. Chalmers SA, Eidelman AS, Ewer JC, et al. A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Cell Immunol 2013;282:136-45.

    43. Atadja P, Wong H, Veillete C, et al. Overexpression of cyclin D1 blocks proliferation of normal diploid fbroblasts. Exp Cell Res 1995;217:205-16.

    44. Chen RC, Yi PP, Zhou RR, et al. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines. Mol Cell Biochem 2014;390:271-80.

    45. Yin Y, Li W, Deng M, et al. Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P-glycoprotein expression in gastric adenocarcinoma cells. Mol Med Rep 2014;9:1439-43.

    46. Bald T, Quast T, Landsberg J, et al. Ultraviolet-radiationinduced infammation promotes angiotropism and metastasis in melanoma. Nature 2014;507:109-13.

    47. Fiuza C, Bustin M, Talwar S, et al. Infammationpromoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652-60.

    48. Treutiger CJ, Mullins GE, Johansson AS, et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375-85.

    49. Gong W, Wang ZY, Chen GX, et al. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF- B signaling via initiation of HSP70. Oncol Rep 2013;30:1249-56.

    50. Das SK, Bhutia SK, Kegelman TP, et al. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front Biosci (Landmark Ed) 2012;17:1-15.

    51. Chetty C, Vanamala SK, Gondi CS, et al. MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 2012;24:549-59.

    52. Sen T, Chatterjee A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor 5 1 in the process. Eur J Nutr 2011;50:465-78.

    53. Chen YY, Chiang SY, Lin JG, et al. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncol 2010;36:1113-20.

    54. Kim A, Kim MJ, Yang Y, et al. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis 2009;30:927-36.

    55. Kanno T, Kamba T, Yamasaki T, et al. JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma. Oncogene 2012;31:3098-110.

    56. Argast GM, Krueger JS, Thomson S, et al. Inducible expression of TGF, snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model. Clin Exp Metastasis 2011;28:593-614.

    Cite this article as:Zhang J, Liu C, Hou R. Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. Chin J Cancer Res 2014;26(6):658-668. doi: 10.3978/j.issn.1000-9604.2014.12.05

    10.3978/j.issn.1000-9604.2014.12.05

    Submitted Oct 15, 2014. Accepted for publication Nov 30, 2014.

    婷婷亚洲欧美| 国产激情偷乱视频一区二区| 99热6这里只有精品| a在线观看视频网站| 一个人观看的视频www高清免费观看| 国产精品久久久久久人妻精品电影| 最近在线观看免费完整版| 国产成人aa在线观看| 午夜老司机福利剧场| www.999成人在线观看| 久久精品国产清高在天天线| 亚洲片人在线观看| 国产不卡一卡二| 精品人妻视频免费看| 老熟妇仑乱视频hdxx| 亚洲va日本ⅴa欧美va伊人久久| 成人精品一区二区免费| av在线老鸭窝| 内地一区二区视频在线| 91麻豆av在线| 欧美丝袜亚洲另类 | 欧美日韩黄片免| netflix在线观看网站| 国产综合懂色| 色视频www国产| 免费观看人在逋| 精品久久久久久久末码| 国产三级黄色录像| 国产蜜桃级精品一区二区三区| av在线观看视频网站免费| 亚洲 欧美 日韩 在线 免费| 国产精品不卡视频一区二区 | 国产精品一区二区性色av| 夜夜看夜夜爽夜夜摸| 欧美日韩瑟瑟在线播放| 成人精品一区二区免费| 中文在线观看免费www的网站| 色综合欧美亚洲国产小说| 一级作爱视频免费观看| 午夜亚洲福利在线播放| 国产精品日韩av在线免费观看| www日本黄色视频网| 国产三级在线视频| 日韩欧美 国产精品| 国产一区二区三区视频了| 在线观看免费视频日本深夜| 色哟哟哟哟哟哟| 国产成+人综合+亚洲专区| 亚洲av熟女| 九色成人免费人妻av| 久久久久久国产a免费观看| 日本精品一区二区三区蜜桃| 变态另类丝袜制服| 精品久久国产蜜桃| 欧美黑人欧美精品刺激| 97超视频在线观看视频| 国产91精品成人一区二区三区| 国产私拍福利视频在线观看| 我的女老师完整版在线观看| 精品人妻视频免费看| 久久久久亚洲av毛片大全| 波多野结衣高清无吗| 每晚都被弄得嗷嗷叫到高潮| 1000部很黄的大片| 人妻夜夜爽99麻豆av| 2021天堂中文幕一二区在线观| 精品人妻1区二区| 亚洲 国产 在线| 激情在线观看视频在线高清| 欧美高清成人免费视频www| 99精品在免费线老司机午夜| 观看免费一级毛片| 内地一区二区视频在线| 亚洲精品456在线播放app | 综合色av麻豆| 国产精品一区二区性色av| 免费看光身美女| www.熟女人妻精品国产| aaaaa片日本免费| 91麻豆av在线| 国产久久久一区二区三区| 亚洲第一欧美日韩一区二区三区| 欧美丝袜亚洲另类 | aaaaa片日本免费| 日韩欧美在线乱码| 日韩人妻高清精品专区| 日本精品一区二区三区蜜桃| 日韩欧美一区二区三区在线观看| av欧美777| 精品人妻视频免费看| av中文乱码字幕在线| 日韩免费av在线播放| 久久国产精品影院| 婷婷亚洲欧美| 日日摸夜夜添夜夜添av毛片 | 中文字幕免费在线视频6| 免费在线观看成人毛片| 最近最新免费中文字幕在线| 狠狠狠狠99中文字幕| 最近视频中文字幕2019在线8| 91麻豆精品激情在线观看国产| 久久精品夜夜夜夜夜久久蜜豆| 日韩欧美精品v在线| 欧美+亚洲+日韩+国产| 全区人妻精品视频| 久久精品国产亚洲av涩爱 | av在线老鸭窝| av黄色大香蕉| 淫妇啪啪啪对白视频| 欧美一级a爱片免费观看看| 又爽又黄a免费视频| 国产色爽女视频免费观看| 一本精品99久久精品77| 国产高清三级在线| 亚洲男人的天堂狠狠| 国产中年淑女户外野战色| 51国产日韩欧美| 狂野欧美白嫩少妇大欣赏| 欧美乱妇无乱码| 免费观看的影片在线观看| 99riav亚洲国产免费| 亚洲欧美日韩卡通动漫| 女生性感内裤真人,穿戴方法视频| 中文亚洲av片在线观看爽| 国产白丝娇喘喷水9色精品| 天天一区二区日本电影三级| 国产亚洲精品av在线| 人妻丰满熟妇av一区二区三区| 在线播放国产精品三级| 亚洲第一电影网av| 亚洲精品乱码久久久v下载方式| 一级av片app| 久久99热6这里只有精品| 性欧美人与动物交配| 成年免费大片在线观看| 熟女人妻精品中文字幕| 免费看美女性在线毛片视频| 少妇裸体淫交视频免费看高清| 搡老妇女老女人老熟妇| а√天堂www在线а√下载| 少妇人妻精品综合一区二区 | 精品一区二区免费观看| 宅男免费午夜| 观看美女的网站| 91在线精品国自产拍蜜月| 国产黄色小视频在线观看| 国产黄色小视频在线观看| 狠狠狠狠99中文字幕| 欧美在线一区亚洲| 亚洲国产精品成人综合色| 日韩欧美免费精品| 天美传媒精品一区二区| 69人妻影院| 一个人观看的视频www高清免费观看| 国产精品久久久久久人妻精品电影| 18禁黄网站禁片午夜丰满| 午夜福利成人在线免费观看| 日韩欧美国产在线观看| 99久久精品一区二区三区| 老熟妇乱子伦视频在线观看| 久久精品91蜜桃| 精品人妻1区二区| 久久人人精品亚洲av| 免费av毛片视频| 一个人免费在线观看的高清视频| 一区二区三区四区激情视频 | 十八禁网站免费在线| 国产精品爽爽va在线观看网站| 90打野战视频偷拍视频| av在线天堂中文字幕| 欧美日韩福利视频一区二区| bbb黄色大片| 欧洲精品卡2卡3卡4卡5卡区| 男女那种视频在线观看| 欧美高清成人免费视频www| 人妻制服诱惑在线中文字幕| 一区二区三区高清视频在线| av中文乱码字幕在线| 亚洲成人中文字幕在线播放| 婷婷色综合大香蕉| 亚洲成人中文字幕在线播放| 美女免费视频网站| 男人舔女人下体高潮全视频| 一a级毛片在线观看| 草草在线视频免费看| www.色视频.com| 一进一出好大好爽视频| 女生性感内裤真人,穿戴方法视频| 国产精品爽爽va在线观看网站| 综合色av麻豆| 一夜夜www| 嫩草影院入口| 欧美乱妇无乱码| 国产美女午夜福利| 麻豆av噜噜一区二区三区| 午夜福利成人在线免费观看| 黄色丝袜av网址大全| 亚洲av成人精品一区久久| 欧美最黄视频在线播放免费| 国产激情偷乱视频一区二区| 国产成+人综合+亚洲专区| 欧美日韩国产亚洲二区| 色5月婷婷丁香| 欧美不卡视频在线免费观看| 99视频精品全部免费 在线| 日韩欧美 国产精品| 欧美在线黄色| 精品乱码久久久久久99久播| 欧美一区二区国产精品久久精品| 免费大片18禁| 一区二区三区免费毛片| 热99re8久久精品国产| 亚洲av不卡在线观看| 国内精品久久久久精免费| 中文资源天堂在线| 在线播放国产精品三级| 老女人水多毛片| 最新在线观看一区二区三区| 99久久成人亚洲精品观看| 丁香六月欧美| 亚洲中文字幕日韩| 亚洲国产精品999在线| 久久久久久久久大av| 色综合站精品国产| 亚洲黑人精品在线| 麻豆国产av国片精品| 亚洲第一欧美日韩一区二区三区| 真实男女啪啪啪动态图| 久久久久免费精品人妻一区二区| 欧美三级亚洲精品| 日本五十路高清| 国产高清视频在线观看网站| 99久久无色码亚洲精品果冻| 国产人妻一区二区三区在| 国产国拍精品亚洲av在线观看| 欧美性感艳星| 久久久久九九精品影院| 婷婷丁香在线五月| 搞女人的毛片| 此物有八面人人有两片| 亚洲国产欧洲综合997久久,| 国产色婷婷99| 免费在线观看影片大全网站| 亚洲国产欧洲综合997久久,| 国产精品嫩草影院av在线观看 | 午夜老司机福利剧场| 高清在线国产一区| 一级黄色大片毛片| 男女做爰动态图高潮gif福利片| 久久久久久久精品吃奶| 亚洲男人的天堂狠狠| 精品福利观看| 国产精品av视频在线免费观看| 啪啪无遮挡十八禁网站| 精品无人区乱码1区二区| 亚洲午夜理论影院| 国产午夜精品久久久久久一区二区三区 | 丰满乱子伦码专区| 久久99热6这里只有精品| 欧美乱色亚洲激情| 亚洲美女黄片视频| 床上黄色一级片| 能在线免费观看的黄片| 日日夜夜操网爽| 国产爱豆传媒在线观看| 成人特级av手机在线观看| 国产成人av教育| 在线播放无遮挡| 亚洲成人精品中文字幕电影| 亚洲av第一区精品v没综合| 成熟少妇高潮喷水视频| 国产黄片美女视频| 免费av毛片视频| 久久性视频一级片| 男女那种视频在线观看| 日本黄色视频三级网站网址| 美女高潮喷水抽搐中文字幕| 99在线视频只有这里精品首页| 欧美最黄视频在线播放免费| 国产爱豆传媒在线观看| 露出奶头的视频| 欧美黄色淫秽网站| 国产精品一区二区三区四区免费观看 | 亚洲精品影视一区二区三区av| 欧美国产日韩亚洲一区| 全区人妻精品视频| 天堂√8在线中文| bbb黄色大片| 在线观看舔阴道视频| 国产野战对白在线观看| 岛国在线免费视频观看| 久久伊人香网站| 欧美日韩黄片免| a级毛片免费高清观看在线播放| 97超级碰碰碰精品色视频在线观看| 久久久久久久久久成人| av欧美777| 一本久久中文字幕| 免费一级毛片在线播放高清视频| 欧美+亚洲+日韩+国产| 国内毛片毛片毛片毛片毛片| 91麻豆av在线| 在线观看66精品国产| 亚洲精品色激情综合| 18禁黄网站禁片午夜丰满| 国产免费男女视频| 久久精品久久久久久噜噜老黄 | 婷婷六月久久综合丁香| 日韩欧美精品免费久久 | 久久精品国产清高在天天线| 日韩有码中文字幕| netflix在线观看网站| 18禁黄网站禁片免费观看直播| 亚洲黑人精品在线| 又黄又爽又刺激的免费视频.| 12—13女人毛片做爰片一| 国产精品爽爽va在线观看网站| 久久久国产成人精品二区| 伦理电影大哥的女人| 日韩欧美一区二区三区在线观看| 午夜精品在线福利| 人人妻人人看人人澡| 91av网一区二区| 色精品久久人妻99蜜桃| 亚洲在线自拍视频| 欧美又色又爽又黄视频| 欧美zozozo另类| 男女那种视频在线观看| 久久精品人妻少妇| 国产黄色小视频在线观看| 久久精品国产亚洲av天美| 在线天堂最新版资源| 久久久久久久午夜电影| 人妻久久中文字幕网| 熟女电影av网| 久久精品综合一区二区三区| 桃色一区二区三区在线观看| 亚洲国产精品合色在线| 国产精品免费一区二区三区在线| 麻豆成人午夜福利视频| 91九色精品人成在线观看| 午夜a级毛片| 99在线视频只有这里精品首页| 在线播放无遮挡| 久久亚洲精品不卡| 99精品久久久久人妻精品| 国产精品99久久久久久久久| 男女做爰动态图高潮gif福利片| 久久久久久久精品吃奶| 国产综合懂色| 成人国产一区最新在线观看| 丝袜美腿在线中文| 欧美一级a爱片免费观看看| 国产av在哪里看| 天天躁日日操中文字幕| 美女被艹到高潮喷水动态| 美女免费视频网站| 欧美乱妇无乱码| 91狼人影院| 草草在线视频免费看| bbb黄色大片| 黄色一级大片看看| 亚洲18禁久久av| 性欧美人与动物交配| 亚洲 欧美 日韩 在线 免费| 最近视频中文字幕2019在线8| 日本三级黄在线观看| 91久久精品电影网| 看十八女毛片水多多多| 精品午夜福利在线看| 日本撒尿小便嘘嘘汇集6| 国语自产精品视频在线第100页| 国产国拍精品亚洲av在线观看| 久久草成人影院| 人妻夜夜爽99麻豆av| 91在线精品国自产拍蜜月| 高潮久久久久久久久久久不卡| 成人三级黄色视频| 欧美成狂野欧美在线观看| 色5月婷婷丁香| 亚洲av免费在线观看| xxxwww97欧美| 熟女电影av网| 免费看美女性在线毛片视频| 国产 一区 欧美 日韩| 免费看a级黄色片| 日韩高清综合在线| 欧美日韩国产亚洲二区| 免费电影在线观看免费观看| 久久99热6这里只有精品| 国产精品亚洲一级av第二区| 嫩草影院精品99| 国产大屁股一区二区在线视频| 日本与韩国留学比较| 禁无遮挡网站| 欧美绝顶高潮抽搐喷水| 精品午夜福利在线看| 色综合欧美亚洲国产小说| 亚洲中文字幕一区二区三区有码在线看| 欧美一区二区亚洲| 99热这里只有是精品50| 欧美在线黄色| 能在线免费观看的黄片| 国语自产精品视频在线第100页| 欧美性猛交黑人性爽| 高清在线国产一区| 自拍偷自拍亚洲精品老妇| 国产亚洲精品久久久com| 内射极品少妇av片p| 九色成人免费人妻av| 免费黄网站久久成人精品 | 亚洲成av人片免费观看| 天天一区二区日本电影三级| 亚洲熟妇熟女久久| 国产精品久久电影中文字幕| 亚洲 国产 在线| 18禁裸乳无遮挡免费网站照片| 91狼人影院| 国产av不卡久久| 日本三级黄在线观看| 亚洲真实伦在线观看| 欧美色视频一区免费| 亚洲精品一卡2卡三卡4卡5卡| 长腿黑丝高跟| 高清在线国产一区| 成人国产一区最新在线观看| 一区二区三区免费毛片| 国产伦在线观看视频一区| 国产成年人精品一区二区| 精品午夜福利视频在线观看一区| 久久热精品热| 久久久久九九精品影院| 757午夜福利合集在线观看| 亚洲国产欧美人成| av在线老鸭窝| 最新中文字幕久久久久| 一级黄片播放器| 亚洲第一区二区三区不卡| 欧美zozozo另类| 亚洲午夜理论影院| 欧美精品国产亚洲| 蜜桃久久精品国产亚洲av| av中文乱码字幕在线| 亚洲国产色片| 女同久久另类99精品国产91| 嫩草影院新地址| 99久久99久久久精品蜜桃| 天堂动漫精品| 在线播放国产精品三级| 搡老岳熟女国产| 在线免费观看不下载黄p国产 | 日本黄大片高清| 色精品久久人妻99蜜桃| 久久精品国产亚洲av涩爱 | 毛片女人毛片| 婷婷精品国产亚洲av| 精品免费久久久久久久清纯| 亚洲中文日韩欧美视频| 精品午夜福利在线看| 丰满人妻熟妇乱又伦精品不卡| 国产真实伦视频高清在线观看 | 97超级碰碰碰精品色视频在线观看| 身体一侧抽搐| 一边摸一边抽搐一进一小说| 日本熟妇午夜| 国产精品爽爽va在线观看网站| 亚洲在线自拍视频| 精品一区二区免费观看| 亚洲欧美精品综合久久99| 99国产极品粉嫩在线观看| 99在线视频只有这里精品首页| 在线观看av片永久免费下载| 99riav亚洲国产免费| 网址你懂的国产日韩在线| 国产伦人伦偷精品视频| 日韩欧美在线乱码| 精品久久久久久久久av| 淫妇啪啪啪对白视频| 久久久久久久久大av| 中文字幕免费在线视频6| 精品久久久久久,| 很黄的视频免费| 91午夜精品亚洲一区二区三区 | 日韩 亚洲 欧美在线| 亚洲精品在线美女| 久久午夜福利片| 亚洲色图av天堂| 亚洲av熟女| 久久精品国产亚洲av涩爱 | 精品欧美国产一区二区三| 亚洲人成网站在线播放欧美日韩| 啪啪无遮挡十八禁网站| 黄色配什么色好看| 搡老妇女老女人老熟妇| 9191精品国产免费久久| 麻豆国产97在线/欧美| 免费观看精品视频网站| 日韩欧美三级三区| av黄色大香蕉| 国产免费av片在线观看野外av| 亚洲av电影不卡..在线观看| 久久国产乱子伦精品免费另类| 精品无人区乱码1区二区| 老熟妇仑乱视频hdxx| 亚洲欧美日韩高清专用| 亚洲国产高清在线一区二区三| www.www免费av| 婷婷精品国产亚洲av| 99久久无色码亚洲精品果冻| 久久久久国产精品人妻aⅴ院| 偷拍熟女少妇极品色| 国产精品不卡视频一区二区 | 99久久精品一区二区三区| 精品午夜福利在线看| 日本一本二区三区精品| 美女黄网站色视频| 精品久久久久久久久久久久久| 搡女人真爽免费视频火全软件 | 亚洲国产精品999在线| 麻豆av噜噜一区二区三区| 亚洲精品一区av在线观看| 一级黄片播放器| 此物有八面人人有两片| 99热6这里只有精品| 亚洲av成人不卡在线观看播放网| 欧美色视频一区免费| 三级国产精品欧美在线观看| 久久午夜亚洲精品久久| 欧美三级亚洲精品| 国产亚洲av嫩草精品影院| 午夜两性在线视频| 午夜免费激情av| 欧美日韩黄片免| 精品欧美国产一区二区三| 亚洲一区二区三区色噜噜| 男插女下体视频免费在线播放| 在线天堂最新版资源| 十八禁人妻一区二区| 亚洲国产高清在线一区二区三| 国产成人影院久久av| 日本黄色视频三级网站网址| 亚洲欧美清纯卡通| 亚洲电影在线观看av| 日本一二三区视频观看| 午夜福利在线观看免费完整高清在 | 一级毛片久久久久久久久女| 搞女人的毛片| 99国产精品一区二区蜜桃av| 国内精品一区二区在线观看| 欧美激情在线99| 伦理电影大哥的女人| 99久久无色码亚洲精品果冻| 亚洲经典国产精华液单 | 精品福利观看| 欧美xxxx黑人xx丫x性爽| 久久国产精品影院| 国产成人影院久久av| 午夜福利在线观看免费完整高清在 | 日韩欧美免费精品| 天天一区二区日本电影三级| av视频在线观看入口| 国产精品1区2区在线观看.| 中亚洲国语对白在线视频| 熟女电影av网| 男人和女人高潮做爰伦理| 91久久精品电影网| x7x7x7水蜜桃| 亚洲国产精品sss在线观看| 人妻久久中文字幕网| 草草在线视频免费看| 国产aⅴ精品一区二区三区波| 97超视频在线观看视频| 亚洲在线观看片| 国产亚洲欧美在线一区二区| 国产精品不卡视频一区二区 | 久久精品国产亚洲av涩爱 | 国产视频内射| 久久国产乱子免费精品| 成人亚洲精品av一区二区| 久久99热这里只有精品18| 十八禁国产超污无遮挡网站| 十八禁网站免费在线| 午夜视频国产福利| 国产精品女同一区二区软件 | 免费无遮挡裸体视频| 性色avwww在线观看| 人妻夜夜爽99麻豆av| 热99re8久久精品国产| 村上凉子中文字幕在线| 老司机午夜福利在线观看视频| 国产精品久久久久久精品电影| 丁香六月欧美| 免费看a级黄色片| 日韩精品中文字幕看吧| 最新在线观看一区二区三区| 高潮久久久久久久久久久不卡| 国产欧美日韩一区二区三| xxxwww97欧美| 亚洲精品亚洲一区二区| 在现免费观看毛片| 国产精品久久久久久久电影| 久久亚洲真实| 欧美激情久久久久久爽电影| 一区二区三区四区激情视频 | 搡老熟女国产l中国老女人| 精品久久国产蜜桃| 精品国内亚洲2022精品成人| 精品久久国产蜜桃| 波多野结衣巨乳人妻| 中文字幕熟女人妻在线| 国产成人a区在线观看| 国产真实伦视频高清在线观看 | 热99re8久久精品国产| 波多野结衣高清无吗| 国产精品美女特级片免费视频播放器|